Experimental drugs poised for use in Ebola outbreak
International health organizations are in discussions with the Democratic Republic of Congo about how and whether to deploy treatments in addition to a vaccine.
Aid workers responding to the Ebola virus outbreak in the Democratic Republic of Congo (DRC) are seeking approval to treat patients with experimental drugs. These include three potential treatments — ZMapp, favipiravir and GS-5734 — that were given to patients during the 2014–16 Ebola outbreak in West Africa. The three drugs are being considered in addition to an existing plan to deploy an experimental vaccine; none of the treatments has been definitively proved to lower the risk of death from Ebola.
By Erika Check Hayden, Nature News